Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $371000.0.

  • MediWound's Change in Accured Expenses rose 16690.65% to $371000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $925000.0, marking a year-over-year increase of 12607.84%. This contributed to the annual value of $517000.0 for FY2024, which is 15571.12% up from last year.
  • Per MediWound's latest filing, its Change in Accured Expenses stood at $371000.0 for Q3 2025, which was up 16690.65% from $3000.0 recorded in Q2 2025.
  • In the past 5 years, MediWound's Change in Accured Expenses registered a high of $1.4 million during Q2 2021, and its lowest value of -$2.0 million during Q2 2022.
  • Its 5-year average for Change in Accured Expenses is -$167625.0, with a median of $71000.0 in 2024.
  • As far as peak fluctuations go, MediWound's Change in Accured Expenses skyrocketed by 29060.4% in 2021, and later crashed by 24316.9% in 2022.
  • MediWound's Change in Accured Expenses (Quarter) stood at $1.4 million in 2021, then tumbled by 243.17% to -$2.0 million in 2022, then surged by 33.15% to -$1.4 million in 2023, then skyrocketed by 130.32% to $412000.0 in 2024, then dropped by 9.95% to $371000.0 in 2025.
  • Its last three reported values are $371000.0 in Q3 2025, $3000.0 for Q2 2025, and $412000.0 during Q4 2024.